Base
Notice2026-016782026-01-28

Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders

Transportation Department, Federal Motor Carrier Safety Administration

Abstract

FMCSA announces receipt of applications from 63 individuals for an exemption from the prohibition in the Federal Motor Carrier Safety Regulations (FMCSRs) against persons with a clinical diagnosis of epilepsy or any other condition that is likely to cause a loss of consciousness or any loss of ability to control a commercial motor vehicle (CMV) to drive in interstate commerce. If granted, the exemptions would enable these individuals who have had one or more seizures and are taking anti-seizure medication to operate CMVs in interstate commerce.

Action & Dates

Action
Notice of applications for exemption; request for comments.
Dates
Comments must be received on or before February 27, 2026.

Public Comment

Comments Close
2026-02-27

Document Excerpt

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Transportation Federal Motor Carrier Safety Administration [Docket No. FMCSA-2025-0014] AGENCY: Federal Motor Carrier Safety Administration (FMCSA), Department of Transportation (DOT). ACTION: Notice of applications for exemption; request for comments. SUMMARY: FMCSA announces receipt of applications from 63 individuals for an exemption from the prohibition in the Federal Motor Carrier Safety Regulations (FMCSRs) against persons with a clinical diagnosis of epilepsy or any other condition that is likely to cause a loss of consciousness or any loss of ability to control a commercial motor vehicle (CMV) to drive in interstate commerce. If granted, the exemptions would enable these individuals who have had one or more seizures and are taking anti-seizure medication to operate CMVs in interstate commerce. DATES: Comments must be received on or before February 27, 2026. ADDRESSES: You may submit comments identified by Docket No. FMCSA-2025-0014 using any of the following methods: Federal eRulemaking Portal: Go to www.regulations.gov , insert the docket number (FMCSA-2025-0014) in the keyword box and click “Search.” Next, choose the only notice listed, and click on the “Comment” button. Follow the online instructions for submitting comments. Mail: Dockets Operations; U.S. Department of Transportation, 1200 New Jersey Avenue SE, West Building Ground Floor, Washington, DC 20590-0001. Hand Delivery: West Building Ground Floor, 1200 New Jersey Aven

Read full document on FederalRegister.gov →

Related Documents

Other Federal Register documents from the same docket.

Full Document

Citation: 91 FR 3775